Net Cash Provided by (Used in) Financing Activities in USD of STANDARD BIOTOOLS INC. from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Standard Biotools Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q1 2025.
  • Standard Biotools Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was -$46K, a 99.8% increase year-over-year.
  • Standard Biotools Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$103M, a 1407% decline from 2023.
  • Standard Biotools Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$6.81M, a 103% decline from 2022.
  • Standard Biotools Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $231M, a 1346% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

STANDARD BIOTOOLS INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$46K +$19.7M +99.8% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025
Q1 2024 -$19.7M -$17.2M -671% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025
Q1 2023 -$2.56M -$20.6M -114% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q1 2022 $18.1M +$19.1M 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q1 2021 -$1.03M -$523K -104% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q1 2020 -$503K -$650K -442% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021
Q1 2019 $147K +$205K 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q1 2018 -$58K -$61K 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019
Q1 2017 $3K* -$5M 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018
Q1 2016 $5M +$1.27M +34% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017
Q1 2015 $3.73M -$194M -98.1% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016
Q1 2014 $197M +$196M +11077% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015
Q1 2013 $1.77M +$4.81M 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014
Q1 2012 -$3.04M -$76.5M -104% 01 Jan 2012 31 Mar 2012 10-Q 09 May 2013
Q1 2011 $73.4M 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012

STANDARD BIOTOOLS INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$103M -$95.8M -1407% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2025
2023 -$6.81M -$238M -103% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025
2022 $231M +$215M +1346% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2025
2021 $16M -$4.9M -23.5% 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2023
2020 $20.9M +$18.1M +648% 01 Jan 2020 31 Dec 2020 10-K 08 Mar 2022
2019 $2.79M -$54.9M -95.2% 01 Jan 2019 31 Dec 2019 10-K 08 Mar 2022
2018 $57.7M +$28.7M +98.8% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021
2017 $29M +$28.9M +24897% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020
2016 $116K -$5.22M -97.8% 01 Jan 2016 31 Dec 2016 10-K 18 Mar 2019
2015 $5.34M -$195M -97.3% 01 Jan 2015 31 Dec 2015 10-K 08 Mar 2018
2014 $200M +$195M +3350% 01 Jan 2014 31 Dec 2014 10-K 03 Mar 2017
2013 $5.81M -$42.7M -88% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016
2012 $48.5M -$21.8M -31% 01 Jan 2012 31 Dec 2012 10-K 26 Feb 2015
2011 $70.4M +$66.6M +1753% 01 Jan 2011 31 Dec 2011 10-K 12 Mar 2014
2010 $3.8M 01 Jan 2010 31 Dec 2010 10-K 12 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.